Redhill Biopharma Ltd. (RDHL) vs Sunshine Biopharma, Inc. (SBFM)

Redhill Biopharma Ltd. and Sunshine Biopharma, Inc. are both Drug Manufacturers Specialty & Generic companies. Redhill Biopharma Ltd. and Sunshine Biopharma, Inc. are of similar size ($3.3M and $3.2M). Sunshine Biopharma, Inc. grew revenue faster over the last twelve months: −2.74% against −61.9%. Redhill Biopharma Ltd. has the higher net margin (25.2% vs −16.5%) and the higher return on invested capital (0.00% vs −26.7%). Across the 16 metrics below, Redhill Biopharma Ltd. leads on 9 and Sunshine Biopharma, Inc. on 7.

Valuation

Metric RDHL SBFM Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.32 0.03 2.25
P/B n/m 0.04 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 2.48 12.29
EV/Sales 0.30 (0.34) 2.56
Earnings yield (122,133.34%) (1,208.33%) (2.99%)
Free cash flow yield (909.75%) (482.76%) 0.00%

Profitability

Metric RDHL SBFM Drug Manufacturers Specialty & Generic median
Gross margin 35.16% 30.30% 53.94%
Operating margin 0.00% (16.65%) 0.00%
Net margin 25.20% (16.50%) 0.00%
Free cash flow margin 0.00% (15.66%) 0.00%
Return on equity 0.00% (21.93%) (0.40%)
Return on assets 0.00% (17.78%) (3.32%)
Return on invested capital 0.00% (26.67%) 0.00%

Growth

Metric RDHL SBFM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (61.93%) (2.74%) 10.01%
EPS growth (last fiscal year) 97.91% 80.33% —
Revenue growth, 5-year CAGR (66.15%) 247.74% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RDHL SBFM Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 0.56 5.46 2.31
Net debt to EBITDA 0.53 2.20 0.85

Dividend

Metric RDHL SBFM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric RDHL SBFM Drug Manufacturers Specialty & Generic median
Market cap 3.22m 3.25m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack